MG
BHVN icon

Marex Group’s Biohaven BHVN Stock Holding History

Marex Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,250
Closed -$425K – 1148
2026
Q1 		$425K Buy
+50,250
New +$550K ﹤0.01% 671

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's BHVN Position: Q2 2026 in Review

Marex Group sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 50,250 shares — an estimated $425K sold.

Marex Group first reported a position in BHVN in Q1 2026 and held it in 1 quarter. The position peaked at $425K in Q1 2026. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Marex Group reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 50,250 Biohaven shares in Q2 2026, an estimated $425K.
  • Marex Group first reported a position in Biohaven in Q1 2026 and held it in 1 quarter.
  • Marex Group's Biohaven position peaked at $425K in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.